Home 2023

Respiratory diseases

StockWatch: Insilico CEO Breaks Down Exelixis Deal
Artificial Intelligence

StockWatch: Insilico CEO Breaks Down Exelixis Deal

Alex Philippidis -
0
Insilico’s AI Tackles Lysosomal Storage Disorder, IPF Drug Gets Inhalable Formula
Artificial Intelligence

Insilico’s AI Tackles Lysosomal Storage Disorder, IPF Drug Gets Inhalable Formula

Julianna LeMieux, PhD -
0
Insilico’s AI Candidate for IPF Doses First Patient in Phase II
Artificial Intelligence

Insilico’s AI Candidate for IPF Doses First Patient in Phase II

Alex Philippidis -
0
Macrophage Cell Culture Model May Boost Respiratory Disease Research
News

Macrophage Cell Culture Model May Boost Respiratory Disease Research

Christina Jackson -
0
IGI Wins $70 Million to Study Microbiome Engineering for Health, Climate Challenges
Drug Discovery

IGI Wins $70 Million to Study Microbiome Engineering for Health, Climate Challenges

Alex Philippidis -
0
Gossamer Stops Development of CNS Lymphoma Candidate after Two Patient Deaths, Partial Hold
Cancer

Gossamer Stops Development of CNS Lymphoma Candidate after Two Patient Deaths, Partial Hold

Alex Philippidis -
0
StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron
GEN Edge

StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron

Alex Philippidis -
0
Polymer Formulation to Improve Existing Antibiotics
Bioprocessing

Polymer Formulation to Improve Existing Antibiotics

John Sterling -
0
Cystic Fibrosis Foundation Funds Nanoparticle Delivery to Lung
News

Cystic Fibrosis Foundation Funds Nanoparticle Delivery to Lung

Julianna LeMieux, PhD -
0
PASTE, Don’t Cut: Genome Editing Tool Looks Beyond CRISPR and Prime
News

PASTE, Don’t Cut: Genome Editing Tool Looks Beyond CRISPR and Prime

Alex Philippidis -
0
123...75Page 1 of 75
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.